Literature DB >> 18706043

Third international stroke trial.

William Whiteley1, Richard Lindley, Joanna Wardlaw, Peter Sandercock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 18706043     DOI： 10.1111/j.1747-4949.2006.00043.x

Source DB:  PubMed          Journal:  Int J Stroke        ISSN： 1747-4930            Impact factor:   5.266


× No keyword cloud information.
  10 in total

Review 1.  [Difficult decisions in stroke therapy].

Authors:  M Endres; M Grond; W Hacke; M Ebinger; P D Schellinger; M Dichgans
Journal:  Nervenarzt       Date:  2011-08       Impact factor: 1.214

Review 2.  How to make better use of thrombolytic therapy in acute ischemic stroke.

Authors:  Geoffrey A Donnan; Stephen M Davis; Mark W Parsons; Henry Ma; Helen M Dewey; David W Howells
Journal:  Nat Rev Neurol       Date:  2011-06-14       Impact factor: 42.937

3.  Thrombolytic therapy for acute ischemic stroke beyond three hours.

Authors:  Christopher R Carpenter; Samuel M Keim; William Kenneth Milne; William J Meurer; William G Barsan
Journal:  J Emerg Med       Date:  2010-06-25       Impact factor: 1.484

4.  Thrombolytic Therapy for Acute Ischemic Stroke.

Authors:  Patrick D Lyden
Journal:  Stroke       Date:  2019-07-22       Impact factor: 7.914

5.  Stroke: Expanded indications for stroke thrombolysis--what next?

Authors:  Geoffrey A Donnan; Stephen M Davis
Journal:  Nat Rev Neurol       Date:  2012-07-31       Impact factor: 42.937

6.  The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

Authors:  Peter Sandercock; Joanna M Wardlaw; Richard I Lindley; Martin Dennis; Geoff Cohen; Gordon Murray; Karen Innes; Graham Venables; Anna Czlonkowska; Adam Kobayashi; Stefano Ricci; Veronica Murray; Eivind Berge; Karsten Bruins Slot; Graeme J Hankey; Manuel Correia; Andre Peeters; Karl Matz; Phillippe Lyrer; Gord Gubitz; Stephen J Phillips; Antonio Arauz
Journal:  Lancet       Date:  2012-05-23       Impact factor: 79.321

7.  Stroke management.

Authors:  Kameshwar Prasad; Subhash Kaul; M V Padma; S P Gorthi; Dheeraj Khurana; Asha Bakshi
Journal:  Ann Indian Acad Neurol       Date:  2011-07       Impact factor: 1.383

8.  Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial.

Authors: 
Journal:  Lancet Neurol       Date:  2015-03-27       Impact factor: 44.182

Review 9.  Thrombolysis for acute ischaemic stroke.

Authors:  Joanna M Wardlaw; Veronica Murray; Eivind Berge; Gregory J del Zoppo
Journal:  Cochrane Database Syst Rev       Date:  2014-07-29

10.  Effect of IV alteplase on the ischemic brain lesion at 24-48 hours after ischemic stroke.

Authors:  Grant Mair; Rüdiger von Kummer; Zoe Morris; Anders von Heijne; Nick Bradey; Lesley Cala; André Peeters; Andrew J Farrall; Alessandro Adami; Gillian Potter; Peter A G Sandercock; Richard I Lindley; Joanna M Wardlaw
Journal:  Neurology       Date:  2018-10-26       Impact factor: 9.910
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.